Salt Lake City, Utah (June 10, 2019) Research and Development Lab Manager Anna Andersen presented results from a recent in-house study on 4Life Transfer Factor® at Immunology 2019™. The event was held at the San Diego Convention Center in San Diego, California and featured presentations by experts in the field.
Chief Scientific Officer Dr. David Vollmer: “This conference gathers the world’s most prominent scientists to discuss the latest developments in immunology. This event is significant because 4Life is the Immune System Company.”
Andersen shared findings from a study that exposed immune system cells to test compounds to activate a response. The goal was to investigate the immune activity of colostrum blends and test the consistency of different batches of 4Life Transfer Factor products.
Andersen: “We knew from previous experiments that 4Life Transfer Factor has strong immune activity, but the results of this experiment were even more impressive. The test results demonstrated a nearly 100% killing of the target cells, which was more effective than the gold standard used in these experiments.”
As the area of immunology expands, 4Life is working hard to stay on its cutting-edge. 4Life is committed to expanding our understanding of 4Life Transfer Factor as well as the immune system in order to provide the most advanced products.
4Life has offices in 25 markets to serve a global network of independent distributors and their customers.
For more information: Calvin Jolley